Abstract
GALECTIN-1, a member of the family of β-galactoside binding proteins1, has growth regulatory and immunomodulatory activities2–4. We report here that galectin-1, expressed by stromal cells in human thymus and lymph nodes5,6, is present at sites of cell death by apoptosis during normal T-cell development and maturation. Galectin-1 induced apoptosis of activated human T cells and human T leukaemia cell lines. Resting T cells also bound galectin-1, but did not undergo apoptosis. Human endothelial cells that expressed galectin-1 induced apoptosis of bound T cells. Galectin-1-induced apoptosis required expression of CD45, and was decreased when N-glycan elongation was blocked by treatment of the cells by swainsonine7, whereas inhibition of O-glycan elongation8 potentiated the apoptotic effect of galectin-1. Induction of apoptosis by an endogenous mammalian lectin represents a new mechanism for regulating the immune response.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Barondes, S. H. et al. Cell 76, 597–598 (1994).
Wells, V. & Mallucci, L. Cell 64, 91–97 (1991).
Levi, G., Tarrab-Hazdai, R. & Teichberg, V. I. Eur. J. Immun. 13, 500–507 (1983).
Offner, H. et al. J. Neuroimmun. 28, 177–184 (1990).
Baum, L. G., Pang, M., Perillo, N. L., Wu, T. & Seilhamer, J. J. J. exp. Med. 181, 877–887 (1995).
Baum, L. G. et al. Glycoconjugate J. 12, 63–68 (1995).
Elbein, A. D. A. Rev. Biochem. 56, 497–534 (1987).
Kuan, S.-F., Byrd, J. C., Basbaum, C. & Kim, Y. S. J. biol. Chem. 264, 19271–19277 (1989).
Hirabayashi, J. & Kasai, K.-i. Glycobiology 3, 297–304 (1993).
Barondes, S. H., Cooper, D. N. W., Gitt, M. A. & Leffler, H. J. biol. Chem. 269, 20807–20810 (1994).
Hughes, R. C. Curr. Opin. struct. Biol. 2, 687–692 (1992).
Liao, D-I., Kapadia, G., Ahmed, H., Vasta, G. R. & Herzberg, O. Proc. natn. Acad. Sci. U.S.A. 91, 1428–1432 (1994).
Bourne, Y. et al. Nature struct. Biol. 1, 863–870 (1994).
Cooper, D. N. W., Massa, S. M. & Barondes, S. H. J. Cell Biol. 115, 1437–1448 (1991).
Allen, H. J. et al. J. Cell Biochem. 43, 43–57 (1990).
Zhou, Q. & Cummings, R. D. Arch. Biochem. Biophys. 300, 6–17 (1993).
Lee, R. T., Ishikawa, Y., Allen, H. J. & Lee, Y. C. J. biol. Chem. 265, 7864–7871 (1990).
Duvall, E. & Wyllie, A. H. Immun. Today 7, 115–119 (1986).
Telford, W. G., King, L. E. & Fraker, P. J. Cytometry 13, 137–143 (1992).
Cho, M. & Cummings, R. D. J. biol. Chem 270, 5207–5212 (1995).
Harrison, F. L. & Chesterton, C. J. FEBS Lett. 122, 157–165 (1980).
Wesselborg, S., Janssen, O. & Kabelitz, D. J. Immun. 150, 4338–4345 (1993).
Goldstone, S. D. & Lavin, M. F. Biochem. biophys. Res. Commun. 178, 746–750 (1991).
Su, X. et al. Immunity 2, 353–362 (1995).
Trauth, B. C. et al. Science 245, 150–157 (1994).
Ong, C. J., Chui, D., Teh, H.-S. & Marth, J. D. J. Immun. 152, 3793–3805 (1994).
Koretzky, G. A., Picus, J., Thomas, M. L. & Weiss, A. Nature 346, 66–68 (1990).
Pulido, R. & Sanchez-Madrid, F. Eur. J. Immun. 20, 2667–2671 (1990).
Bezouska, K. et al. Nature 372, 150–157 (1994).
Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. J. Cell Biol. 119, 493–501 (1992).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Perillo, N., Pace, K., Seilhamer, J. et al. Apoptosis of T cells mediated by galectin-1. Nature 378, 736–739 (1995). https://doi.org/10.1038/378736a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/378736a0
Further reading
-
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
Cancer Immunology, Immunotherapy (2022)
-
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis
Oncogenesis (2021)
-
Chemokines modulate glycan binding and the immunoregulatory activity of galectins
Communications Biology (2021)
-
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Nature Reviews Clinical Oncology (2021)
-
Arsenic trioxide as a novel anti-glioma drug: a review
Cellular & Molecular Biology Letters (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.